Predicting global healthcare in 2040

Allianz Partners’ ‘The World in 2040’ Series has been launched. It will examine a wide range of future trends and topics that will impact healthcare and travel over the next 20 years. This includes how multiple medical revolutions will improve and extend life.

The first report in the Series will focus on the changes expected in healthcare over the next two decades, including significant improvements in the delivery of treatment and access to care.

Over the next two decades, it predicts several major revolutions will transform how medicine is practised and how healthcare is delivered. These revolutions include:

  • Personalised medicine – based on personal DNA analysis and electronic health data collected from individual patients
  • Stem-cell medicine – the use of stem cells to repair/regrow tissue and organs
  • Nano-scale medicine gene-editing – altering human DNA to improve health
  • Digital health – using AI and digital technology to diagnose and to monitor patient health

Each of these five revolutions would individually transform the prospects for human health and longevity. But, taken together, they will produce an entirely new paradigm for healthcare – one in which consumers will collect their own health data, geneticists will remove hereditary diseases from the population, artificial intelligence (AI) systems will routinely aid diagnosis and treatments will be tailored and personalised for individual patients.

Today, there are about 7.6 billion people on the planet. The United Nations forecasts that by 2030, that number will have risen to 8.5 billion and by 2040, it will have reached over 9 billion. And the number of people living in the world will keep going up. By 2100, there will be 11.2 billion.